Michelin | Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital Clermont-Ferrand, February 12th, 2026 COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN Partnership Limited by Shares (commandite par actions) having a capital of EUR 343,798,729Registered in the CLERMONT-FERRAND Trade and companies register under number 855 200 887Head office: 23, place des Carmes-Déchaux - 63000 Clermont-Ferrand, France Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital (Articles L.233-8 of the Fre...
Michelin | Déclaration du nombre total des droits de vote et du nombre d'actions composant le capital social Clermont-Ferrand, le 12 février 2026 COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELINSociété en commandite par actions au capital de € 343 798 729855 200 887 R.C.S. CLERMONT-FERRANDSiège social : 23, place des Carmes-Déchaux - 63000 Clermont-Ferrand Déclaration du nombre total des droits de vote et du nombre d'actions composant le capital social(articles L.233-8 du Code de commerce et 223-16 du règlem...
A director at Vivendi sold 345,517 shares at 2.290EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...
Michelin delivered segment operating income of €2.9 billion in 2025, at constant exchange rates. The Group generated high free cash flow before M&A of €2.1 billion and strengthened its financial position. Clermont-Ferrand, February 11, 2026 – 5:45pm COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN Michelin delivered segment operating income of €2.9 billion in 2025, at constant exchange rates.The Group generated high free cash flow before M&A of €2.1 billion and strengthened its financial position. Group sales and segment operating income were weighed down by lower business volumes and the...
Michelin enregistre en 2025 un résultat opérationnel des secteurs de 2,9 milliards € à iso-parités et un cash-flow libre avant M&A élevé, de 2,1 milliards €, renforçant ainsi sa solidité financière. Clermont-Ferrand, le 11 février 2026 – 17h45 COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN Michelin enregistre en 2025 un résultat opérationnel des secteurs de 2,9 milliards € à iso-parités et un cash-flow libre avant M&A élevé, de 2,1 milliards €, renforçant ainsi sa solidité financière. Les ventes et le résultat opérationnel des secteurs sont pénalisés par le volume d’activité et l’appréci...
In today's Morning Views publication we comment on developments of the following high yield issuers: Verisure, AMS Osram, International Personal Finance, Bombardier, TK Elevator, Rekeep, Ontex, TUI, Allwyn (formerly Sazka), Samvardhana Motherson, Adler Pelzer, Canpack, Iceland Foods
Danone: Information on the total number of voting rights and shares DANONE French Société anonyme with a capital of €170,348,620.75.Registered Office: 59-61, rue La Fayette, 75009 Paris.Registered with the Paris Commerce and Company Registry under number 552 032 534 Information on the total number of voting rights and shares in compliance with Article L. 233-8 II of the French Commercial Code and with Article 223-16 of the General Regulation of the Financial Markets Authority (AMF- Autorité des Marchés Financiers) DateTotal number of sharesTotal number of voting rights31/01/2026681,394...
DANONE : Informations relatives au nombre total de droits de vote et d’actions DANONE Société anonyme à Conseil d’Administration au capital de 170 348 620,75 €.Siège social : 59-61, rue La Fayette, 75 009 Paris.552 032 534 R.C.S. Paris. Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du code de commerce et l’article 223-16 du règlement général de l’Autorité des marchés financiers DateNombre d’actionsNombre total de droits de vote31/01/2026681 394 483Nombre de droits de vote théoriques (1) : 721 388 853Nombre de droit de votes exerç...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: MAPFRE, TALGO. EUROPA: DANONE, UNICREDIT. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’25 que se publicarán en España y Europa en los próximos días. Continúa la volatilidad en las bolsas Semana de volatilidad en las bolsas europeas tras los vaivenes en las materias primas y las dudas sobre las valoraci...
Michelin to acquire Flexitallic, accelerating growth in Polymer Composite Solutions Clermont-Ferrand, February 3rd, 2026 COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN Michelin to acquire Flexitallic, accelerating growth in Polymer Composite Solutions Michelin announces the acquisition of Flexitallic to develop its leadership in the Sealing segment.Polymer Composite Solutions accelerates growth, will soon become a specific reporting segment in Group’s financial communication.Deal fully financed in cash, financi...
Michelin annonce l’acquisition de Flexitallic et accélère la croissance de son activité Polymer Composite Solutions Clermont-Ferrand, le 03 février 2026 COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN Michelin annonce l’acquisition de Flexitallic et accélère la croissance de son activité Polymer Composite Solutions Michelin annonce l’acquisition de Flexitallic afin de renforcer son leadership dans le domaine des joints.Accélération de la croissance de l’activité Polymer Composite Solutions, qui deviendra prochainement un segment de reporting spécifi...
RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA mRNA-3927 is a strong strategic fit with Recordati’s rare Metabolic portfolio Collaboration combines Moderna’s expertise in mRNA technology for rare metabolic disorders with Recordati’s established global rare disease commercial infrastructure Moderna will continue to lead development for mRNA-3927, and if approved, Recordati will lead global commercialization efforts Milan, 29 January 2026 – Recordati today announced that it has entered into a...
RECORDATI ANNUNCIA UNA COLLABORAZIONE STRATEGICA CON MODERNA PER SVILUPPARE E COMMERCIALIZZARE A LIVELLO GLOBALE mRNA-3927 PER IL TRATTAMENTO DELL’ACIDEMIA PROPIONICA mRNA-3927 si inserisce strategicamente nel portafoglio delle malattie rare metaboliche di Recordati La collaborazione unisce l’expertise di Moderna nella tecnologia mRNA per i disturbi metabolicirari con la solida infrastruttura commerciale globale di Recordati nelle malattie rare Moderna continuerà a guidare lo sviluppo di mRNA-3927 e, in caso di approvazione, Recordati guiderà la commercializzazione a livello globale Mila...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.